Bactericidal activity of erythromycin associated with sulphisoxazole against the infectious agents most frequently responsible for acute infantile otitis media.
Bonacorsi
S
S
Bingen
E
E
D001419:Bacteria / Q000187:drug effects*; D002648:Child; D004359:Drug Therapy, Combination / Q000494:pharmacology*; D004917:Erythromycin / Q000494:pharmacology; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D001936:Moraxella catarrhalis / Q000187:drug effects; D010033:Otitis Media / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013444:Sulfisoxazole / Q000494:pharmacology
D004917:Erythromycin; D013444:Sulfisoxazole